Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic drug interactions with phenytoin (Part II).

Literature DB >> 2180613

Pharmacokinetic drug interactions with phenytoin (Part II).

R L Nation¹, A M Evans, R W Milne.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1990 PMID： 2180613 DOI： 10.2165/00003088-199018020-00004

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

309 in total

1. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.

Authors: J J Crowley; B J Cusack; S G Jue; J R Koup; B K Park; R E Vestal
Journal: J Pharmacol Exp Ther Date: 1988-05 Impact factor: 4.030

2. Interaction between phenytoin and imipramine.

Authors: E Perucca; A Richens
Journal: Br J Clin Pharmacol Date: 1977-08 Impact factor: 4.335

3. Effect of diphenylhydantoin on cortisol kinetics in humans.

Authors: Y Choi; K Thrasher; E E Werk; L J Sholiton; C Olinger
Journal: J Pharmacol Exp Ther Date: 1971-01 Impact factor: 4.030

4. Phenytoin-dexamethasone: a possible drug-drug interaction.

Authors: D D Wong; R G Longenecker; M Liepman; S Baker; M LaVergne
Journal: JAMA Date: 1985-10-18 Impact factor: 56.272

5. Gastrointestinal dialysis with activated charcoal and cathartic in the treatment of adolescent intoxications.

Authors: H C Mofenson; T R Caraccio; J Greensher; R D'Agostino; A Rossi
Journal: Clin Pediatr (Phila) Date: 1985-12 Impact factor: 1.168

6. Enzyme induction in neonates after fetal exposure to antiepileptic drugs.

Authors: D Rating; E Jäger-Roman; H Nau; W Kuhnz; H Helge
Journal: Pediatr Pharmacol (New York) Date: 1983

7. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.

Authors: T L Svendsen; M B Kristensen; J M Hansen; L Skovsted
Journal: Eur J Clin Pharmacol Date: 1976-03-22 Impact factor: 2.953

8. Treatment of phenytoin toxicity with repeated doses of activated charcoal.

Authors: G D Weichbrodt; D P Elliott
Journal: Ann Emerg Med Date: 1987-12 Impact factor: 5.721

9. Plasma protein binding interaction between phenytoin and valproic acid in vitro.

Authors: A Monks; S Boobis; J Wadsworth; A Richens
Journal: Br J Clin Pharmacol Date: 1978-12 Impact factor: 4.335

10. Effect of phenytoin on meperidine clearance and normeperidine formation.

Authors: S M Pond; K M Kretschzmar
Journal: Clin Pharmacol Ther Date: 1981-11 Impact factor: 6.875

9 in total

1. The 'apparent clearance' of free phenytoin in elderly vs. younger adults.

Authors: Daniel F B Wright; Evan J Begg
Journal: Br J Clin Pharmacol Date: 2010-07 Impact factor: 4.335

2. Acute phenytoin intoxication in a 4-year-old mimicking viral meningoencephalitis.

Authors: Amlin Shukla; Jhuma Sankar; Ankit Verma; Nandkishore Dubey
Journal: BMJ Case Rep Date: 2013-06-25

Review 3. Epilepsy in the elderly.

Authors: Ilo E Leppik; Angela K Birnbaum
Journal: Ann N Y Acad Sci Date: 2010-01 Impact factor: 5.691

Review 4. Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans.

Authors: U Fuhr
Journal: Clin Pharmacokinet Date: 2000-06 Impact factor: 6.447

5. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.

Authors: Bernhards R Ogutu; Charles R J C Newton; Simon N Muchohi; Godfrey O Otieno; Geoffrey Edwards; William M Watkins; Gilbert O Kokwaro
Journal: Br J Clin Pharmacol Date: 2003-07 Impact factor: 4.335